Bristol Other Assets from 2010 to 2025

BMY Stock  USD 59.14  0.38  0.65%   
Bristol Myers Other Assets yearly trend continues to be fairly stable with very little volatility. Other Assets will likely drop to about 3.3 B in 2025. During the period from 2010 to 2025, Bristol Myers Other Assets regression line of annual values had r-squared of  0.24 and arithmetic mean of  3,022,724,049. View All Fundamentals
 
Other Assets  
First Reported
2000-03-31
Previous Quarter
3.3 B
Current Value
3.8 B
Quarterly Volatility
5.8 B
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bristol Myers financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bristol Myers' main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.8 B, Interest Expense of 1.4 B or Selling General Administrative of 3.6 B, as well as many indicators such as Price To Sales Ratio of 2.98, Dividend Yield of 0.0374 or PTB Ratio of 6.92. Bristol financial statements analysis is a perfect complement when working with Bristol Myers Valuation or Volatility modules.
  
Check out the analysis of Bristol Myers Correlation against competitors.

Latest Bristol Myers' Other Assets Growth Pattern

Below is the plot of the Other Assets of Bristol Myers Squibb over the last few years. It is Bristol Myers' Other Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bristol Myers' overall financial position and show how it may be relating to other accounts over time.
Other Assets10 Years Trend
Slightly volatile
   Other Assets   
       Timeline  

Bristol Other Assets Regression Statistics

Arithmetic Mean3,022,724,049
Geometric Mean2,691,453,990
Coefficient Of Variation51.54
Mean Deviation1,108,064,555
Median2,877,000,000
Standard Deviation1,557,824,019
Sample Variance2426815.7T
Range6.2B
R-Value0.49
Mean Square Error1971423.7T
R-Squared0.24
Significance0.05
Slope160,900,988
Total Sum of Squares36402235.1T

Bristol Other Assets History

20253.3 B
20243.3 B
20222.9 B
20213.3 B
20207.3 B
20194.8 B
20182.2 B

About Bristol Myers Financial Statements

Bristol Myers investors use historical fundamental indicators, such as Bristol Myers' Other Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bristol Myers. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Assets3.3 B3.3 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bristol Stock Analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.